Dermapharm Holding Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Hans-George Feldmeier
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.6yrs |
| CEO ownership | n/a |
| Management average tenure | 3yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
CEO
Hans-George Feldmeier
5.6yrs
Tenure
Dr. Hans-George Feldmeier is the Chief Executive Officer and Chairman of the Management Board at Dermapharm Holding SE and also serves as Member of the Management Board from August 2017.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Management Board | 5.6yrs | no data | no data | |
| CFO & CCO | less than a year | no data | no data | |
| Member of the Management Board & Chief Business Development Officer | 5.6yrs | no data | no data | |
| Head of Investor Relations & Corporate Communications | no data | no data | no data | |
| Chief Marketing Officer | less than a year | no data | no data |
3.0yrs
Average Tenure
Experienced Management: DMPH.F's management team is considered experienced (3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Member of Supervisory Board | 5.2yrs | €80.00k | no data | |
| Chairman of the Supervisory Board | 5.6yrs | €80.00k | no data | |
| Vice Chairman of the Supervisory Board | 5.6yrs | €80.00k | no data |
5.6yrs
Average Tenure
Experienced Board: DMPH.F's board of directors are considered experienced (5.6 years average tenure).